Betancor, D. et al. 2024. Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics. Allergologia et Immunopathologia. 52, 6 (Nov. 2024), 76–78. DOI:https://doi.org/10.15586/aei.v52i6.1161.